At present, the company can produce enough kits to test about 2 million people weekly and the first batch will prioritize fever clinics and pediatric outpatient departments across the country.

Experts said patients suffering from novel coronavirus pneumonia and influenza may show similar clinical symptoms, such as fever, sore throat, cough and fatigue, and even CT scan images of their lungs may look similar.

The kit provides doctors with a more efficient tool of quick pathogen identification for influenza patients and suspected novel coronavirus patients.